关注
Anil Philip
Anil Philip
在 unizwa.edu.om 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Colon targeted drug delivery systems: a review on primary and novel approaches
AK Philip, B Philip
Oman medical journal 25 (2), 79, 2010
5722010
Global burden of cardiovascular diseases and risks, 1990-2022
GA Mensah, V Fuster, CJL Murray, GA Roth, AK Philip
Journal of the American College of Cardiology, 2350-2473, 2023
4012023
Modified transdermal technologies: Breaking the barriers of drug permeation via the skin
R Kumar, A Philip
Tropical journal of pharmaceutical research 6 (1), 633-644, 2007
3432007
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in …
GBD Collborators, Philip A.K
The Lancet, 2024
3322024
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the …
Anil K. Philip, GBD Collaborators
The Lancet, 2024
3322024
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease …
M Brauer, GA Roth, Aravkin, GBD Collborators, Anil K. Philip
The Lancet 403 (10440), 2162-2203, 2024
3132024
Drug delivery: principles and applications
B Wang, L Hu, TJ Siahaan
John Wiley & Sons, 2016
2822016
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021
SE Vollset, HS Ababneh, Abate, GBD Collaborators, Anil K Philip
The Lancet 403 (10440), 2204-2256, 2024
1322024
Osmotic flow through asymmetric membrane: a means for controlled delivery of drugs with varying solubility
AK Philip, K Pathak
Aaps Pharmscitech 7, E1-E11, 2006
1052006
Optimized prodrug approach: A means for achieving enhanced anti-inflammatory potential in experimentally induced colitis
AK Philip, S Dabas, K Pathak
Journal of drug targeting 17 (3), 235-241, 2009
862009
Dendrimers: Nanotechnology derived novel polymers in drug delivery
S Pushkar, A Philip, K Pathak, D Pathak
Indian Journal of Pharmaceutical Education and Research 40 (3), 153, 2006
852006
Gastroretentive dosage forms for prolonging gastric residence time
R Kumar, A Philip
International Journal of Pharmaceutical Medicine 21, 157-171, 2007
792007
Optimization studies on design and evaluation of orodispersible pediatric formulation of indomethacin
J Singh, AK Philip, K Pathak
Aaps Pharmscitech 9, 60-66, 2008
772008
Asymmetric membrane in membrane capsules: a means for achieving delayed and osmotic flow of cefadroxil
AK Philip, K Pathak, P Shakya
European Journal of Pharmaceutics and Biopharmaceutics 69 (2), 658-666, 2008
712008
Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
NV Bhattacharjee, GBD Collborators, Philip A.K.
The Lancet, 2024
692024
Wet process-induced phase-transited drug delivery system: a means for achieving osmotic, controlled, and level A IVIVC for poorly water-soluble drug
AK Philip, K Pathak
Drug development and industrial pharmacy 34 (7), 735-743, 2008
572008
Optimizing delivery of flurbiprofen to the colon using a targeted prodrug approach
AK Philip, RK Dubey, K Pathak
Journal of Pharmacy and Pharmacology 60 (5), 607-613, 2008
562008
Modified polysaccharides as fast disintegrating excipients for orodispersible tablets of roxithromycin
V Sharma, AK Philip, K Pathak
Aaps Pharmscitech 9, 87-94, 2008
552008
Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
Wu, Dongze et, AK Philip
EClinicalMedicine 64, 2023
442023
In situ-formed asymmetric membrane capsule for osmotic release of poorly water-soluble drug
A Philip, K Pathak
PDA Journal of Pharmaceutical Science and Technology 61 (1), 24-36, 2007
442007
系统目前无法执行此操作,请稍后再试。
文章 1–20